Literature DB >> 23605000

Pulmonary cytokine composition differs in the setting of alcohol use disorders and cigarette smoking.

Ellen L Burnham1, Elizabeth J Kovacs, Christopher S Davis.   

Abstract

Alcohol use disorders (AUDs), including alcohol abuse and dependence, and cigarette smoking are widely acknowledged and common risk factors for pneumococcal pneumonia. Reasons for these associations are likely complex but may involve an imbalance in pro- and anti-inflammatory cytokines within the lung. Delineating the specific effects of alcohol, smoking, and their combination on pulmonary cytokines may help unravel mechanisms that predispose these individuals to pneumococcal pneumonia. We hypothesized that the combination of AUD and cigarette smoking would be associated with increased bronchoalveolar lavage (BAL) proinflammatory cytokines and diminished anti-inflammatory cytokines, compared with either AUDs or cigarette smoking alone. Acellular BAL fluid was obtained from 20 subjects with AUDs, who were identified using a validated questionnaire, and 19 control subjects, matched on the basis of age, sex, and smoking history. Half were current cigarette smokers; baseline pulmonary function tests and chest radiographs were normal. A positive relationship between regulated and normal T cell expressed and secreted (RANTES) with increasing severity of alcohol dependence was observed, independent of cigarette smoking (P = 0.0001). Cigarette smoking duration was associated with higher IL-1β (P = 0.0009) but lower VEGF (P = 0.0007); cigarette smoking intensity was characterized by higher IL-1β and lower VEGF and diminished IL-12 (P = 0.0004). No synergistic effects of AUDs and cigarette smoking were observed. Collectively, our work suggests that AUDs and cigarette smoking each contribute to a proinflammatory pulmonary milieu in human subjects through independent effects on BAL RANTES and IL-1β. Furthermore, cigarette smoking additionally influences BAL IL-12 and VEGF that may be relevant to the pulmonary immune response.

Entities:  

Keywords:  interleukins; pneumococcus; pneumonia; regulated and normal T cell expressed and secreted

Mesh:

Substances:

Year:  2013        PMID: 23605000      PMCID: PMC3680749          DOI: 10.1152/ajplung.00385.2012

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  69 in total

1.  The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury.

Authors:  Joslyn M Albright; Christopher S Davis; Melanie D Bird; Luis Ramirez; Hajwa Kim; Ellen L Burnham; Richard L Gamelli; Elizabeth J Kovacs
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

2.  Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing.

Authors:  Aysegul V Ergen; Nathan C Boles; Margaret A Goodell
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

3.  Effects of long term ethanol consumption mediated oxidative stress on neovessel generation in liver.

Authors:  Subir Kumar Das; Sukhes Mukherjee; D M Vasudevan
Journal:  Toxicol Mech Methods       Date:  2012-03-17       Impact factor: 2.987

4.  Cigarette smoke impacts immune inflammatory responses to influenza in mice.

Authors:  Clinton S Robbins; Carla M T Bauer; Neda Vujicic; Gordon J Gaschler; Brian D Lichty; Earl G Brown; Martin R Stämpfli
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

5.  The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease.

Authors:  Amit Srivastava; Philipp Henneke; Alberto Visintin; Sarah C Morse; Victoria Martin; Claire Watkins; James C Paton; Michael R Wessels; Douglas T Golenbock; Richard Malley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Cytokines and alcohol.

Authors:  Fulton T Crews; Rabih Bechara; Lou Ann Brown; David M Guidot; Pranoti Mandrekar; Shilpa Oak; Liya Qin; Gyongyi Szabo; Michael Wheeler; Jian Zou
Journal:  Alcohol Clin Exp Res       Date:  2006-04       Impact factor: 3.455

7.  CCL5 modulates pneumococcal immunity and carriage.

Authors:  Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Rajesh Singh; Edwin W Ades; David E Briles; Susan K Hollingshead; Walter Royal; Jacquelyn S Sampson; Jonathan K Stiles; Dennis D Taub; James W Lillard
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

8.  Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities.

Authors:  Mohammed Reza Shariatzadeh; Jane Q Huang; Gregory J Tyrrell; Marcia M Johnson; Thomas J Marrie
Journal:  Medicine (Baltimore)       Date:  2005-05       Impact factor: 1.889

9.  Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history.

Authors:  Reza Karimi; Göran Tornling; Johan Grunewald; Anders Eklund; C Magnus Sköld
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

10.  T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.

Authors:  Daniel R Neill; Vitor E Fernandes; Laura Wisby; Andrew R Haynes; Daniela M Ferreira; Ameera Laher; Natalie Strickland; Stephen B Gordon; Paul Denny; Aras Kadioglu; Peter W Andrew
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

View more
  18 in total

1.  Presence of an Alcohol Use Disorder is Associated with Greater Pneumonia Severity in Hospitalized HIV-Infected Patients.

Authors:  Sarah E Jolley; Qasim Alkhafaf; Catherine Hough; David A Welsh
Journal:  Lung       Date:  2016-07-12       Impact factor: 2.584

2.  The impact of alcohol use disorders on pulmonary immune cell inflammatory responses to Streptococcus pneumoniae.

Authors:  Jeanette Gaydos; Alicia McNally; Ellen L Burnham
Journal:  Alcohol       Date:  2018-09-05       Impact factor: 2.405

3.  Donor smoking is associated with pulmonary edema, inflammation and epithelial dysfunction in ex vivo human donor lungs.

Authors:  L B Ware; J W Lee; N Wickersham; J Nguyen; M A Matthay; C S Calfee
Journal:  Am J Transplant       Date:  2014-08-21       Impact factor: 8.086

4.  Alveolar macrophage inflammatory mediator expression is elevated in the setting of alcohol use disorders.

Authors:  Eileen Bock O'Halloran; Brenda J Curtis; Majid Afshar; Michael M Chen; Elizabeth J Kovacs; Ellen L Burnham
Journal:  Alcohol       Date:  2015-11-24       Impact factor: 2.405

Review 5.  Environmental risk factors for acute respiratory distress syndrome.

Authors:  Farzad Moazed; Carolyn S Calfee
Journal:  Clin Chest Med       Date:  2014-09-30       Impact factor: 2.878

6.  Autologous serum supplement favours in vitro regenerative paracrine factors synthesis.

Authors:  Nazmul Haque; Noor Hayaty Abu Kasim; Noor Lide Abu Kassim; Mohammad Tariqur Rahman
Journal:  Cell Prolif       Date:  2017-07-06       Impact factor: 6.831

7.  Response of Differentiated Human Airway Epithelia to Alcohol Exposure and Klebsiella Pneumoniae Challenge.

Authors:  Sammeta V Raju; Richard G Painter; Gregory J Bagby; Steve Nelson; Guoshun Wang
Journal:  Med Sci (Basel)       Date:  2013-07-26

8.  The Relationship Between Airway Antioxidant Levels, Alcohol Use Disorders, and Cigarette Smoking.

Authors:  Ellen L Burnham; Alicia McNally; Jeanette Gaydos; Lou Ann S Brown
Journal:  Alcohol Clin Exp Res       Date:  2016-09-14       Impact factor: 3.455

9.  Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells.

Authors:  Jeanette Gaydos; Alicia McNally; Ruixin Guo; R William Vandivier; Philip L Simonian; Ellen L Burnham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

10.  Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation.

Authors:  Farzad Moazed; Ellen L Burnham; R William Vandivier; Cecilia M O'Kane; Murali Shyamsundar; Umar Hamid; Jason Abbott; David R Thickett; Michael A Matthay; Daniel F McAuley; Carolyn S Calfee
Journal:  Thorax       Date:  2016-02-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.